CirculatingTumor Cells: Toward a clinical benefit? Giuseppe Naso MD, PhD, Associated Professor of Medical Oncology Director of Traslational Oncology Paola.
Circulating Tumor Cells and Their Prognostic and Predictive Value in Breast Cancer Massimo Cristofanilli, M.D., F.A.C.P. Professor and Chairman Medical.
